Table 4.
Diagnostic performance for MMG, and US on a per-patient and per-lesion basis
| Modality and group | Study numbers | Conventional meta-analysis summary | Bivariate meta-analysis summary | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Sensitivity (95% CI) | Specificity (95% CI) | DOR (95% CI) | AUC | Q* | Sensitivity (95% CI) | Specificity (95% CI) | Correlation | ||
| Perpatient | |||||||||
| MMG | 12 | 0.82 (0.80–0.84) | 0.91 (0.91–0.92) | 24.34 (10.555–56.127) | 0.8933 | 0.8242 | 0.82 (0.76–0.87) | 0.84 (0.73–0.92) | − 0.2587 |
| US | 13 | 0.74 (0.72–0.76) | 0.89 (0.88–0.90) | 24.19 (14.824–39.463) | 0.8998 | 0.8310 | 0.83 (0.71–0.91) | 0.84 (0.74–0.91) | − 0.8085 |
| Per lesion | |||||||||
| MMG | 7 | 0.78 (0.74–0.81) | 0.90 (0.89–0.91) | 13.84 (5.577–34.357) | 0.8503 | 0.7814 | 0.76 (0.62–0.86) | 0.82 (0.66–0.91) | − 0.3041 |
| US | 7 | 0.94 (0.91–0.95) | 0.85 (0.84–0.86) | 63.219 (27.949–142.99) | 0.9138 | 0.8463 | 0.94 (0.87–0.97) | 0.79 (0.63–0.89 | − 0.6907 |